Sareum Holdings (SAR.L) Stock Price
£12.5 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
0 -
Technical
1
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Sareum Holdings, AI stock picks, stock alerts and much more.
SAR.L AI Stock Analysis
AI stock analysis for SAR.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Sareum Holdings (SAR.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Sareum Holdings (SAR.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Sareum Holdings (SAR.L), currently trading at £12.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About SAR.L
-
Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
-
Symbol
SAR.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
16.7M
Similar Stocks
 |
Codexis 0I0X.L |
$2.58 2% |
3 |
 |
Oxford Nanopore Technologies plc ONT.L |
£111.5 1.7% |
5 |
 |
Viridian Therapeutics 0K1R.L |
$15.35 0.2% |
5 |
 |
Avacta Group Plc AVCT.L |
£40.2 3.1% |
3 |
 |
ImmuPharma IMM.L |
£3.5 4.8% |
4 |
News
SAR.L Alternative Data
Web Traffic
Sareum Holdings receives an estimated 4650 monthly visitors to sareum.com.
-
Web Traffic
4650
-
Change from Previous Month
42%
-
3 Month Change
450.9%
-
YoY Change
450.9%
News Mentions
Sareum Holdings was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Sareum Holdings has 1,639 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
1639
-
Daily Change
0.1%
-
1 Month Change
0.5%
-
3 Month Change
1.4%
LinkedIn Followers
1,234 are following Sareum Holdings on LinkedIn, up by 2.7% over the last month.
-
LinkedIn Followers
1234
-
Daily Change
0%
-
1 Month Change
2.7%
-
3 Month Change
3.5%
Job Postings
Sareum Holdings currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Sareum Holdings has 6 employees.
-
LinkedIn Employees
6
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Sareum Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
SAR.L Financials
SAR.L Key Metrics
-
Total Revenue
£0
-
Net Income
-£911K
-
Earnings per Share
-£0.0112
-
Free cash flow
£0
-
EBITDA
-£2M
-
EBITDA Ratio
0
-
Total Assets
£2.8M
SAR.L 2-year Revenue & Income
SAR.L 2-year Free Cash Flow
SAR.L Technicals
SAR.L SMA
SAR.L RSI
FAQ
What's the current price of Sareum Holdings (SAR.L) Stock?
The price of an Sareum Holdings (SAR.L) share is £12.5.
What's the market cap of Sareum Holdings?
The current market cap of Sareum Holdings is 16.7M.
Should I buy or sell SAR.L?
Sareum Holdings exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Sareum Holdings a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Sareum Holdings stock. There are several bearish signals and market challenges that could negatively impact Sareum Holdings' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Sareum Holdings (SAR.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Sareum Holdings stock right now, as the outlook appears bearish.
What are some stocks similar to Sareum Holdings (SAR.L) that investors often compare it to?
Sareum Holdings (SAR.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Viridian Therapeutics, Avacta Group Plc and ImmuPharma.
What is the forecast for Sareum Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Sareum Holdings' stock price to be around £11.39 in 2026. Starting from the current price of £12.5, this represents a 8.9% change in price, indicating a bearish outlook for the stock.
How to buy Sareum Holdings (SAR.L) Stock?
Sareum Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Sareum Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.